Cargando…

GSK3-beta as a candidate therapeutic target in soft tissue sarcomas

Soft tissue sarcoma (STS) is a predominantly fatal rare malignancy with inadequate treatment options. Glycogen synthase kinase 3β (GSK-3β) is an emerging target in human malignancies. Its therapeutic relevance in STS is unknown. We analyzed the prognostic impact of GSK-3β gene and protein expression...

Descripción completa

Detalles Bibliográficos
Autores principales:	Verbeke, S., Perret, R., Chaire, V., Richard, E., Velasco, V., Giles, F., Cavalcante, L., Italiano, A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8641200/ https://www.ncbi.nlm.nih.gov/pubmed/34857030 http://dx.doi.org/10.1186/s13045-021-01215-x

Ejemplares similares

Genome-wide CRISPR/Cas9 library screening identified ATM signaling network genes as critical drivers for resistance to ATR inhibition in soft-tissue sarcomas: synthetic lethality and therapeutic implications
por: Spalato-Ceruso, M, et al.
Publicado: (2023)

ATR Inhibition Broadly Sensitizes Soft-Tissue Sarcoma Cells to Chemotherapy Independent of Alternative Lengthening Telomere (ALT) Status
por: Laroche-Clary, Audrey, et al.
Publicado: (2020)

BRCA1 haplotype and clinical benefit of trabectedin in soft-tissue sarcoma patients
por: Laroche-Clary, A, et al.
Publicado: (2015)

PD1/PD-L1 targeting in advanced soft-tissue sarcomas: a pooled analysis of phase II trials
por: Italiano, Antoine, et al.
Publicado: (2020)

Activity of trabectedin and the PARP inhibitor rucaparib in soft-tissue sarcomas
por: Laroche, Audrey, et al.
Publicado: (2017)

Prognostic impact of circulating tumor cells in patients with soft‐tissue sarcomas: a prospective study
por: Blanchi, Julie, et al.
Publicado: (2023)

Gene expression profiling improves prognostication by nomogram in patients with soft‐tissue sarcomas
por: Crombé, Amandine, et al.
Publicado: (2022)

PRIMA-1(MET) induces death in soft-tissue sarcomas cell independent of p53
por: Grellety, Thomas, et al.
Publicado: (2015)

Clinical utility of circulating tumor DNA sequencing with a large panel in patients with advanced soft‐tissue sarcomas
por: Blanchi, Julie, et al.
Publicado: (2023)

LRRC15 Targeting in Soft-Tissue Sarcomas: Biological and Clinical Implications
por: Ben-Ami, Eytan, et al.
Publicado: (2020)

Antitumor Effects of PRMT5 Inhibition in Sarcomas
por: Verbeke, Stéphanie, et al.
Publicado: (2023)

Comparison between trabectedin and doxorubicin in soft-tissue sarcomas-reply letter
por: Dang, Jing-Yi, et al.
Publicado: (2022)

Comment on ‘Elevated preoperative neutrophil/lymphocyte ratio is associated with poor prognosis in soft-tissue sarcoma patients': neutrophil to lymphocyte ratio may be predictor of mortality in patients with soft-tissue sarcoma
por: Balta, S, et al.
Publicado: (2013)

ATYPICAL PRESENTATION OF SOFT TISSUE SARCOMA
por: Rizzo, Victoria, et al.
Publicado: (2017)

Treatment and prognosis of iliac fossa soft tissue sarcoma: A single‐center study
por: Sun, Wei, et al.
Publicado: (2020)

Whole‐exome sequencing in clear cell sarcoma of soft tissue uncovers novel prognostic categorization and drug targets
por: Li, Jingjing, et al.
Publicado: (2021)

Therapeutic Targets for Bone and Soft-Tissue Sarcomas
por: Miwa, Shinji, et al.
Publicado: (2019)

Iatrogenic implantation of soft tissue sarcoma at skin graft donor site: Delayed manifestation of an avoidable complication
por: Pai, Vishwas D., et al.
Publicado: (2015)

An atypical presentation of alveolar soft part sarcoma of tongue
por: Chopra, Neha, et al.
Publicado: (2017)

Reply: Comment on ‘Elevated preoperative neutrophil/lymphocyte ratio is associated with poor prognosis in soft-tissue sarcoma patients'
por: Szkandera, J, et al.
Publicado: (2013)

Post‐operative minimal residual disease models to study metastatic relapse in soft‐tissue sarcoma patient‐derived xenografts
por: Fischer, Suzanne, et al.
Publicado: (2023)

New therapeutics for soft tissue sarcomas: Overview of current immunotherapy and future directions of soft tissue sarcomas
por: Seong, Gyuhee, et al.
Publicado: (2023)

High Prevalence of 5T4/Trophoblast Glycoprotein in Soft Tissue Sarcomas
por: Groothuis, Patrick, et al.
Publicado: (2021)

Targeting Lymphotoxin Beta and Paired Box 5: a potential therapeutic strategy for soft tissue sarcoma metastasis
por: Huang, Runzhi, et al.
Publicado: (2021)

Editorial: New therapeutics for soft tissue sarcomas
por: Weetall, Marla, et al.
Publicado: (2023)

Phenoxy herbicides, chlorophenols, soft-tissue sarcoma (STS) and malignant lymphoma.
por: Hardell, L.
Publicado: (1993)

Soft tissue covers in hypospadias surgery: Is tunica vaginalis better than dartos flap?
por: Chandrasekharam, V. V. S., et al.
Publicado: (2012)

Retroperitoneal Soft Tissue Sarcoma: Emerging Therapeutic Strategies
por: de Bree, Eelco, et al.
Publicado: (2023)

Proteomic and Metabolomic Profiling in Soft Tissue Sarcomas
por: Chadha, Madhumeeta, et al.
Publicado: (2022)

Integrated molecular characterization of adult soft tissue sarcoma for therapeutic targets
por: Kim, Jihyun, et al.
Publicado: (2018)

Do patients with soft-tissue sarcomas treated with trabectedin have better clinical effects and a longer survival time than those treated with doxorubicin?
por: Wu, Jiangfeng, et al.
Publicado: (2022)

Improving Immunotherapy Efficacy in Soft-Tissue Sarcomas: A Biomarker Driven and Histotype Tailored Review
por: Roulleaux Dugage, Matthieu, et al.
Publicado: (2021)

Soft-tissue Sarcomas
por: Vodanovich, Domagoj Ante, et al.
Publicado: (2018)

Targeted Treatment of Soft-Tissue Sarcoma
por: Riskjell, Anne Iren, et al.
Publicado: (2023)

Mycobacterium doricum Osteomyelitis and Soft Tissue Infection
por: Pettit, April C., et al.
Publicado: (2011)

Soft tissue coverage in open fractures of tibia
por: Nema, Sandeep, et al.
Publicado: (2013)

Myoepithelioma of soft tissue and diagnostic pitfall in cytology
por: Joob, Beuy, et al.
Publicado: (2018)

Soft-tissue infection due to Mycoplasma hominis
por: Castillo, Ana Ruiz, et al.
Publicado: (2023)

Early symptoms of bone and soft tissue sarcomas: could they be diagnosed earlier?
por: Maguire, Mike
Publicado: (2012)

Translational evidence for RRM2 as a prognostic biomarker and therapeutic target in Ewing sarcoma
por: Ohmura, Shunya, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hqto9dfbeaekgkggnmie1tna2v